Skip to main content
. 2022 May 20;10(5):812. doi: 10.3390/vaccines10050812

Table 2.

Association between vaccination against COVID-19 and mortality in bivariate analysis.

Variables Mortality after 28 Days Mortality after 90 Days
No (n = 961) Yes (n = 592) p No (n = 939) Yes (n = 614) p
n (%) n (%) n (%) n (%)
Vaccinated * 0.003 0.012
Unvaccinated 903 (61.1) 576 (38.9) 884 (59.8) 595 (40.2)
At least one dose 58 (78.4) 16 (21.6) 55 (74.3) 19 (25.7)
Age (years) ** 50.4 ± 16.2 63.1 ± 14.7 0.001 50.1 ± 16.2 63.1 ± 14.6 0.001
Sex * 0.001 0.001
Female 447 (69.1) 200 (30.9) 437 (67.5) 210 (32.5)
Male 514 (56.7) 392 (43.3) 502 (55.4) 404 (44.6)
Symptoms at the onset of the disease
Dyspnea * 0.001 0.001
No 564 (78.9) 142 (20.1) 556 (78.7) 150 (21.3)
Yes 397 (46.9) 450 (53.1) 383 (45.2) 464 (54.8)
Fever * 0.009 0.013
No 636 (64.3) 353 (35.7) 621 (62.8) 368 (37.2)
Yes 325 (57.6) 239 (42.4) 318 (56.4) 246 (43.6)
Cough * 0.001 0.001
No 198 (48.1) 213 (51.8) 190 (46.2) 221 (53.8)
Yes 763 (66.8) 379 (33.2) 749 (65.6) 393 (34.4)
Comorbidity
Hypertension * 0.001 0.001
No 945 (65.0) 509 (35.0) 923 (63.5) 531 (36.5)
Yes 14 (14.4) 83 (85.6) 14 (14.4) 83 (85.6)
Type 2 diabetes * 0.001 0.001
No 953 (62.7) 568 (37.3) 931 (61.2) 590 (38.8)
Yes 6 (20.0) 24 (80.0) 6 (20.0) 24 (80.0)
Chronic kidney disease * 0.001 <0.001
No 955 (62.3) 578 (37.7) 934 (60.9) 599 (39.1)
Yes 4 (22.2) 14 (77.8) 3 (16.7) 15 (83.3)
Obesity * <0.001 <0.001
No 954 (62.9) 562 (37.1) 932 (61.5) 584 (38.5)
Yes 5 (14.3) 30 (85.7) 5 (14.3) 30 (85.7)
Cancer * 0.822 0.453
No 938 (61.9) 578 (38.1) 918 (60.5) 598 (39.5)
Yes 21 (60.0) 14 (40.0) 19 (54.3) 16 (45.7)
Neurological * <0.001 <0.001
No 956 (62.6) 570 (37.4) 934 (61.2) 592 (39.8)
Yes 3 (12.0) 22 (88.0) 3 (12.0) 22 (88.0)

* p-value obtained through chi-squared test. ** p-value obtained through Student’s t-test for independent samples and equal two-tailed variances.